Stay updated with breaking news from Strong Catalyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change with the US FDA’s acceptance of a New Drug ...
At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change with the US FDA’s acceptance of a New Drug ...
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for inflammatory skin conditions.
MoonLake Immunotherapeutics (NASDAQ: MLTX) released topline results from its Phase 2 MIRA trial evaluating the Nanobody sonelokimab in patients with moderate-to-severe
MoonLake Immunotherapeutics (NASDAQ:MLTX) released topline results from its Phase 2 MIRA trial evaluating the Nanobody sonelokimab in patient...